ArticleRespiratory research2026

Modulation of immune responses by elexacaftor/tezacaftor/ivacaftor therapy in cystic fibrosis: data from a compassionate use program.

Francesca Lucca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.